Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Baxter International Inc BAX

Healthcare Medical Devices
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes... see more

Recent & Breaking News (NYSE:BAX)

Baxter to Present at the 2014 Credit Suisse Healthcare Conference

Business Wire October 22, 2014

Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency

Business Wire October 20, 2014

Baxter's Third Quarter Financial Results Exceed Guidance

Business Wire October 16, 2014

Baxter International Third Quarter 2014 Financial Results Conference Call

Business Wire October 9, 2014

Baxter Recognized for Commitment to Women's Healthcare Careers

Business Wire October 8, 2014

Rockwell Medical Enters Into Exclusive Long-Term Agreement With Baxter Healthcare to Commercialize Rockwell's Hemodialysis Concentrates

GlobeNewswire October 3, 2014

Baxter International Inc. Recognized by Healthcare Businesswomen's Association with ACE Award for Its Baxter Women Leaders Business Resource Group

Business Wire October 1, 2014

Baxter to Form New Global Innovation and R&D Center near Boston for Its Biopharmaceuticals Business

Business Wire September 29, 2014

Baxter International Third Quarter 2014 Financial Results Conference Call

Business Wire September 25, 2014

Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and Commercialize Novel Cancer Compound MM-398

Business Wire September 24, 2014

FDA Approves Baxter's RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with Hemophilia B

Business Wire September 15, 2014

FDA Approves Baxter's HYQVIA for Treatment of Adults with Primary Immunodeficiency

Business Wire September 12, 2014

Baxter Announces Baxalta as the Name of New Global Biopharmaceutical Company

Business Wire September 10, 2014

Baxter Announces Hemodialysis Dialyzer Expansion in Opelika, Alabama

Business Wire August 19, 2014

Baxter to Present at Morgan Stanley Global Healthcare Conference

Business Wire August 18, 2014

Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite

Business Wire August 7, 2014

FDA Approves Baxter's FLEXBUMIN 5%, First and Only 5% Human Albumin Solution in a Flexible Container

Business Wire August 4, 2014

FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter's HyQvia for Primary Immunodeficiency

Business Wire July 31, 2014

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer

Business Wire July 30, 2014

Baxter Declares Quarterly Dividend

Business Wire July 22, 2014